Impala Asset Management LLC Moderna, Inc. Transaction History

Impala Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $478,124 - $720,840	-4,082 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $103,444 - $192,270	-818 Reduced 16.69%	4,082 $703,000
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $131,653 - $214,841	-583 Reduced 10.63%	4,900 $1.25 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $1.22 Million - $2.66 Million	5,483 New	5,483 $2.11 Million

1,030

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $20.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Impala Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Impala Asset Management LLC with notifications on news.